GSDMD and malignant colon neoplasm: GSDMD-NT forms pores on the plasma membrane of colon cancer cells, enabling NE (released with NETs) to enter the colon cancer cells and even penetrate into the nucleus, damaging and lysing the cells (Fig. 2B).